Ambrx Intellectual Property
Ambrx owns and controls a comprehensive intellectual property portfolio that dominates incorporation of non-native amino acids into biosynthetic proteins.
Our Intellectual property rights cover:
- Orthogonal tRNAs, synthetases and host cells: bacterial, yeast and mammalian
- Methods of making orthogonal tRNA and synthetase molecules
- Proteins containing non-natural amino acids
- Classes of proteins (cytokines, chemokines, antibodies, peptides) as well as specific proteins
- Types of chemical modification (PEGylation, glycosylation, etc.)
- Specific chemistries
- Methods of use - therapeutic, diagnostic, research applications
- Novel amino acids
- Novel Polymers
We are also the exclusive commercial licensee under intellectual property rights owned by The Scripps Research Institute and the University of California at Berkeley. These rights reinforce our position as the leader in using chemically specified amino acids for the discovery and development of therapeutic proteins, diagnostics, research applications and other products.
